Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 1999, p. 628-632, Vol. 37, No. 3
Pneumococcal Diseases Research Unit of MRC,
SAIMR, WITS, Department of Clinical Microbiology and Infectious
Diseases, South African Institute for Medical Research, Johannesburg
2000, South Africa
Received 20 August 1998/Returned for modification 13 October
1998/Accepted 12 November 1998
A seminested PCR assay, based on the amplification of the
pneumococcal pbp1A gene, was developed for the detection of
penicillin resistance in clinical isolates of Streptococcus
pneumoniae. The assay was able to differentiate between
intermediate (MICs = 0.25 to 0.5 µg/ml) and higher-level
(MICs =
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Application of pbp1A PCR in
Identification of Penicillin-Resistant Streptococcus
pneumoniae
1 µg/ml) resistance. Two species-specific primers,
1A-1 and 1A-2, which amplified a 1,043-bp region of the
pbp1A penicillin-binding region, were used for pneumococcal detection. Two resistance primers, 1A-R1 and 1A-R2, were designed to
bind to altered areas of the pbp1A gene which, together
with the downstream primer 1A-2, amplify DNA from isolates with
penicillin MICs of
0.25 and
1 µg/ml, respectively. A total of 183 clinical isolates were tested with the pbp1A assay. For
98.3% (180 of 183) of these isolates, the PCR results obtained were in
agreement with the MIC data. The positive and negative predictive
values of the assay were 100 and 91%, respectively, for detecting
strains for which the MICs were
0.25 µg/ml and were both 100% for
strains for which the MICs were
1 µg/ml.
*
Corresponding author. Mailing address: Pneumococcal
Diseases Research Unit, SAIMR, P.O. Box 1038, Johannesburg 2000, South Africa. Phone: 27-11-4899335. Fax: 27-11-4899332. E-mail:
mignondp{at}hotmail.com.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|